United Therapeutic
(UTHR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Sales | 358,880 | 281,497 | 210,943 | 159,632 | 115,915 |
| Cost of Goods | 40,861 | 30,066 | 22,261 | 17,028 | 12,315 |
| Gross Profit | 318,019 | 251,431 | 188,682 | 142,604 | 103,600 |
| Operating Expenses | 293,123 | 333,553 | 182,640 | 113,650 | 61,022 |
| Operating Income | 25,757 | -82,056 | 6,303 | 28,982 | 42,893 |
| Interest Expense | 12,875 | 11,439 | 14,281 | 482 | 29 |
| Other Income | 5,741 | 9,774 | 12,455 | 11,408 | 4,658 |
| Pre-tax Income | 18,623 | -83,721 | 4,477 | 39,908 | 47,522 |
| Income Tax | -695 | -34,394 | -7,876 | -34,057 | -17,494 |
| Net Income Continuous | 19,318 | -49,327 | 12,353 | 73,965 | 65,016 |
| Net Income Discontinuous | 144 | N/A | N/A | N/A | N/A |
| Net Income | $19,462 | $-49,327 | $12,353 | $73,965 | $65,016 |
| EPS Basic Total Ops | 0.37 | -1.08 | 0.29 | 1.61 | 1.43 |
| EPS Basic Continuous Ops | 0.36 | -1.08 | 0.29 | 1.61 | 1.42 |
| EPS Basic Discontinuous Ops | 0.01 | N/A | N/A | N/A | N/A |
| EPS Diluted Total Ops | 0.35 | -1.08 | 0.28 | 1.53 | 1.29 |
| EPS Diluted Continuous Ops | 0.34 | -1.08 | 0.28 | 1.53 | 1.29 |
| EPS Diluted Discontinuous Ops | 0.01 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $54,416 | $-63,849 | $19,366 | $30,446 | $45,307 |